Reduction of 3,4-diaminopyridine-induced biogenic amine synthesis and release in rat brain by gabapentin

Psychopharmacology

Volumn 137, Issue 1, 1998, Pages 74-80

  Pugsley, Thomas A ^a   Whetzel, Steven Z ^a   Dooley, David J ^a  

^a PFIZER INC   (United States)

Author keywords

3,4 Diaminopyridine; Biogenic amine synthesis; Gabapentin; Norepinephrine release; Rat brain regions

Indexed keywords

3,4 DIAMINOPYRIDINE; BIOGENIC AMINE; CALCIUM CHANNEL; GABAPENTIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; HIPPOCAMPUS; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; 5-HYDROXYTRYPTOPHAN; ACETIC ACIDS; AMINES; ANIMALS; ANTICONVULSANTS; BIOGENIC MONOAMINES; BRAIN; CYCLOHEXANECARBOXYLIC ACIDS; DIHYDROXYPHENYLALANINE; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031956282     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050595     Document Type: Article

References (39)

1. Andén N-E, Leander S (1979) Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the rat. J Neural Transm 44:1-12
2. Bartoszyk GD, Meyerson N, Reimann W, Satzinger G, von Hodenberg A (1986) Gabapentin. In: Meldrum BS, Porter RJ (eds) Current problems in epilepsy: new anticonvulsant drugs. John Libbey, London, pp 147-164
3. Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in rat brain: an in vivo microdialysis study. J Neurochem 59: 1702-1708
4. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV (1972) Simultaneous measurements of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch Pharmacol 275:153-168
5. Chadwick D (1994) Gabapentin. Lancet 343:89-91
6. Dimond KR, Pande AC, Lamoreaux L, Pierce MV (1996) Effect of gabapentin (Neurontin®) on mood and well-being in patients with epilepsy. Prog Neuropsychopharmacol Psychiatry 20: 407-417
7. Dooley DJ, Suman-Chauhan N, Madden Z (1996) Modulation of stimulation-evoked neurotransmitter release from rat brain slices by the anticonvulsant gabapentin. Soc Neurosci 22:1992
8. 2δ subunit of a calcium channel. J Biol Chem 271:5768-5776
9. Glover WE (1982) The aminopyridines. Gen Pharmacol 13: 259-285
10. Gotz E, Feuerstein TJ, Meyer DK (1993) Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 43:636-638
11. 3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 244:303-309
12. Huang HY, Hertting G, Allgaier C, Jackisch R (1989) 3,4-Diaminopyridine-induced noradrenaline release from CNS tissue as a model for action potential-evoked transmitter release: effects of phorbol ester. Eur J Pharmacol 169:115-123
13. Jimenez-Rivera CA, Waterhouse BD (1991) The role of noradrenergic systems in seizure disorder. In: Fisher RS, Coyle JT (eds) Neurotransmitters and epilepsy. Wiley-Liss, New York, pp 109-129
14. Loscher W, Honack D, Taylor CP (1991) Gabapentin increases aminoxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 128:150-154
15. Macdonald RL, Kelly KM (1994) Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35 [Suppl 4]:S41-S50
16. Okada M, Kaneko S, Hirano T, Mizuno K, Kondo T, Otani K, Fukushima Y (1995) Effects of zonisamide on dopaminergic system. Epilepsy Res 22:193-205
17. Olsen RW (1981) GABA-benzodiazepine-barbiturates receptor interactions. J Neurochem 37:1-13
18. 3 agonist PD 128907. J Pharmacol Exp Ther 275:1355-1356
19. Regan WM, Gordon SM (1997) Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol 17:59-60
20. Reimann W (1983) Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 94:341-343
21. Rosner H, Rubin L, Kestenbaum A (1996) Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 12:56-58
22. B receptor agonists and antagonists. Brain Res 630:28-31
23. Schlicker E, Reiman W, Gothert M (1985) Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelforschung 35:1347-1349
24. Shimoyama N, Shimoyama M, Davis AM, Inturris CE, Elliot KJ (1997) Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 22:65-67
25. Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, Woodruff GN (1996) The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127:1-9
26. Stewart BH, Kugler AR, Thompson PR, Bockbrader HN (1993) A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 10:276-281
27. Su T-Z, Lunney E, Campbell G, Oxender DL (1995) Transport of gabapentin, a gamma-amino acid drug, by system L alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 64:2125-2131
28. 3H]gabapentin binding to a novel site in rat brain: homosenate binding studies. Eur J Pharmacol [Mol Pharmacol Sec] 244:293-301
29. Takebayashi M, Motohashi N, Saito H, Kagaya A, Yamawaki S (1995) Effect of acute treatment with sodium valproate on catecholamine and serotonin synthesis in mouse cerebral cortex. Biol Psychiatry 32:124-127
30. Tapia R, Sitges M, Morales E (1985) Mechanism of the calcium-dependent stimulation of transmitter release by 4-aminopyridine in synaptosomes. Brain Res 361:373-382
31. Taylor CP (1995) Gabapentin mechanism of action. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs 4th edn. Raven Press, New York, pp 829-841
32. +2 and glutamate release. J Neurochem 53:1693-1699
33. Versteeg DHG, Heemskerk EMJ, Spierenburg HA, deGraan PNE, Schrama EH (1995) 4-Aminopyridine differentially affects the spontaneous release of radiolabelled transmitters from rat brain slices in vitro. Brain Res 686:233-238
34. Vriend JP (1996) Lamotrigine decreases the in situ activity of tyrosine hydroxylase in caudate nucleus of normal and seizure-prone BALB/C mice. Soc Neurosci 22:2092
35. Vriend JP, Alexiuk NAM (1995) Lamotrigine dramatically decreases content of dopamine-metabolites in caudate nucleus of normal and seizure-prone BALB/C mice. Soc Neurosci 21: 1967
36. Whitton PS, Oreskovic D, Jernej B, Bulat M (1985) Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain. J Pharm Pharmacol 37:199-200
37. Wise CD, Berger BD, Stein L (1972) Benzodiazepines: anxiety reducing activity by reduction of serotonin turnover in the rat brain. Science 177:180-183
38. Van QS, Mishra PK, Burger RL, Bettendorf AF, Jobe PC, Dailey JW (1992) Evidence that carbamazepine and antiepilepserine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. J Pharmacol Exp Ther 261:652-659
39. Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O (1994) Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 35: 121-127